Drugs / rMenB+OMV NZ
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01911221 | Aug 2013 → Apr 2014 | meningococcal infection | Novartis Vaccines | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | rMenB+OMV NZ | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01911221 ↗ |
| Modality | Vaccine | “Novartis Meningococcal B Recombinant Vaccine” NCT01911221 ↗ |
| Route | Intramuscular | “administered intramuscularly in the deltoid muscle” NCT01911221 ↗ |